Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Charu Aggarwal, MD, MPH

Charu Aggarwal, MD, MPH Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Aggarwal is a Penn Medicine employed physician.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2011
  • Internal Medicine, 2008
  • Medical Oncology, 2011

Clinical Expertise:

  • Head and Neck Cancer
  • Lung Cancer

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 2nd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Lady Hardinge Medical College
Residency: SUNY at Buffalo Medical Center
Fellowship: Fox Chase Cancer Center

Memberships

American Association of Cancer Research, National American Society of Clinical Oncology, National

Hospital Affiliation

Dr. Aggarwal is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans TL, Langer CJ: Determinants of Survival in Advanced Non-Small Cell Lung Cancer in the Era of Targeted Therapies Clinical Lung Cancer : 2013.

Aggarwal, C: Nab-paclitaxel is a valuable NSCLC therapy option Community Oncology 10 (6): 2013.

Aggarwal C, Dahlberg SE, Hanna N, Kolesar J, Hirsch FR, Ramalingam SS and Schiller JH: Exploratory biomarker analyses from ECOG 4508: Three-arm randomized phase II study of carboplatin and paclitaxel in combination with cetuximab, IMC-A12, or both for advanced non-small cell lung cancer patients Journal of Clinical Oncology 31s (abstr 8106): 2013.

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans TL, Langer CJ: Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist? Lung Cancer : 2013.

Lustgarten DS, Deshpande C, Aggarwal C, Wang LC, Saloura V, Vachani A, Wang LP, Litzky L, Feldman M, Creaney J, Nowak AK, Langer CJ, Inghilleri S, Stella G, Albelda SM: Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma Journal of Thoracic Oncology Volume 8 (4) : 469–477,2013.

Aggarwal, C and Langer, CJ: Recent advances in the management of advanced Non Small Cell Lung Cancer Community Oncology 10 (4): 2013.

Aggarwal C, Meropol N J, Punt C J, Iannotti N, Saidman B H, Sabbath K D, Gabrail N Y, Picus J, Morse M A, Mitchell E, Miller M C, Cohen S J: Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 24 (2): 420-8,2013.

Aggarwal C, Ranganathan A, Lustgarten DS et al: Circulating Tumor Cells In Patients With Small Cell Lung Cancer: A Marker Of Disease Burden, Therapeutic Response, And Predictor Of Disease Relapse Journal of Thoracic Oncology : 2012.

Brady A, McNeill JD, Judy B, Evans T, Cohen RB, Langer C, Vachani A AND Aggarwal C: Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer patients treated with first-line chemotherapy Journal of Clinical Oncology Supplement : 2012.

Ranganathan A, Schwed-Lustgarten D, Aggarwal C et al: Circulating tumor cells in patients with small cell lung cancer: a marker of disease burden, therapeutic response, and predictor of disease relapse Journal of Clinical Oncology Supplement : 2012.

Academic Contact Info

Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-207
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 662-6318
Fax: (215) 349-5326
Patient appointments: 800-789-PENN (7366)